PDMR
|
Position
|
Ordinary Shares granted under the AZDBP
|
Ordinary Shares granted under the AZPSP
|
Award price per Ordinary Share
|
Pascal Soriot
|
Executive Director and Chief Executive Officer
|
14,448
|
85,808
|
£108.21
|
Aradhana Sarin
|
Executive Director and Chief Financial Officer
|
7,403
|
38,046
|
£108.21
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
| ||
a)
|
Name
|
Pascal Soriot
| |
2
|
Reason for the notification
| ||
a)
|
Position/status
|
Chief Executive Officer
| |
b)
|
Initial notification /Amendment
|
Initial notification
| |
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
a)
|
Name
|
AstraZeneca PLC
| |
b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08
| |
4i
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary Shares of US$0.25 each in AstraZeneca PLC
GB0009895292
| |
b)
|
Nature of the transaction
|
Grants of share awards under the AstraZeneca Performance Share Plan and the AstraZeneca Deferred Bonus Plan
| |
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£108.21
|
100,256
| ||
d)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable - single transaction
| |
e)
|
Date of the transaction
|
4 March 2023
| |
f)
|
Place of the transaction
|
Outside a trading venue
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
| ||
a)
|
Name
|
Aradhana Sarin
| |
2
|
Reason for the notification
| ||
a)
|
Position/status
|
Chief Financial Officer
| |
b)
|
Initial notification/Amendment
|
Initial notification
| |
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
a)
|
Name
|
AstraZeneca PLC
| |
b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08
| |
4i
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary Shares of US$0.25 each in AstraZeneca PLC
GB0009895292
| |
b)
|
Nature of the transaction
|
Grants of share awards under the AstraZeneca Performance Share Plan and the AstraZeneca Deferred Bonus Plan
| |
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£108.21
|
45,449
| ||
d)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable - single transaction
| |
e)
|
Date of the transaction
|
4 March 2023
| |
f)
|
Place of the transaction
|
Outside a trading venue
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
AstraZeneca plc published this content on 08 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 March 2023 11:46:04 UTC.